15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $604M | $71M | 0.0% | 0.0% | $357M | $9.8B | $467M |
| 2024 | $568M | $243M | -89.1% | 0.0% | $334M | $8.7B | $120M |
| 2023 | $527M | $306M | -71.0% | 0.0% | $182M | $6.9B | $118M |
| 2022 | $495M | $500M | -74.4% | 0.0% | -$62M | $6.5B | $72M |
| 2021 | $471M | $506M | -64.1% | 0.0% | $36M | $6.2B | $158M |
| 2020 | $436M | $414M | -79.3% | 0.0% | -$30M | $6.6B | $44M |
| 2019 | $144M | $46M | -180.8% | 0.0% | $169M | $6.3B | $80M |
| 2018 | $144M | $1.1B | -162.6% | 0.0% | $288M | $5.5B | $54M |
| 2017 | $524M | $414M | -27.1% | 0.0% | $375M | $7.8B | $55M |
| 2016 | — | $628M | — | — | $755M | $9.1B | $95M |
| 2015 | — | -$559M | — | — | $837M | $11.0B | $347M |
| 2014 | — | $922M | — | — | $976M | $9.7B | $182M |
| 2013 | — | $971M | — | — | — | $8.6B | $301M |
| 2012 | — | $833M | — | — | — | $8.6B | $248M |
| 2011 | — | $539M | — | — | — | $7.6B | $34M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $200M | $194M | 0.0% | 0.0% | — | $10.4B | $1.2B |
| Dec '25 | $156M | $114M | 0.0% | 0.0% | — | $9.8B | $467M |
| Sep '25 | $150M | -$117M | -94.0% | 0.0% | — | $9.1B | $91M |
| Jun '25 | $149M | $32M | -85.5% | 0.0% | — | $9.0B | $89M |
| Mar '25 | $149M | $43M | -83.4% | 0.0% | — | $8.9B | $71M |
| Dec '24 | $146M | $5M | -89.8% | 0.0% | — | $8.7B | $120M |
| Sep '24 | $143M | $86M | -96.2% | 0.0% | — | $8.6B | $180M |
| Jun '24 | $141M | $146M | -94.4% | 0.0% | — | $8.6B | $107M |
| Mar '24 | $139M | $7M | -75.6% | 0.0% | — | $8.8B | $102M |
| Dec '23 | $136M | $71M | -64.6% | 0.0% | — | $6.9B | $118M |
| Sep '23 | $134M | $64M | -73.9% | 0.0% | — | $6.7B | $63M |
| Jun '23 | $130M | $52M | -70.4% | 0.0% | — | $6.6B | $104M |
| Mar '23 | $127M | $119M | -75.5% | 0.0% | — | $6.5B | $59M |
| Dec '22 | $126M | $7M | -75.2% | 0.0% | — | $6.5B | $72M |
| Sep '22 | $122M | $354M | -80.3% | 0.0% | — | $6.6B | $112M |
| Jun '22 | $125M | $68M | -71.5% | 0.0% | — | $6.5B | $73M |
| Mar '22 | $122M | $72M | -70.5% | 0.0% | — | $6.3B | $89M |
| Dec '21 | $119M | $29M | -67.6% | 0.0% | — | $6.2B | $158M |
| Sep '21 | $119M | $55M | -69.8% | 0.0% | — | $5.5B | $201M |
| Jun '21 | $117M | $276M | -62.1% | 0.0% | — | $5.1B | $97M |
How the market has priced DOC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Healthpeak Properties's revenue has grown 6.7% per year, and net income declined 29.6% per year. These are computed facts, not advice.
As of FY2025, Healthpeak Properties reported $9.8B of total debt against $467M of cash.
In FY2025, gross margin was —, operating margin —, and net margin 11.8%.
As of Jun '26, Healthpeak Properties traded at a price-to-earnings ratio of about 205.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.